Ticker Details
Kymera Therapeutics, Inc.
IPO Date:	August 21, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$6.49B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.25 | 3.08%
Avg Daily Range (30 D):	$1.72 | 2.03%
Avg Daily Range (90 D):	$1.77 | 2.19%

Institutional Daily Volume
Avg Daily Volume:	.47M
Avg Daily Volume (30 D):	.38M
Avg Daily Volume (90 D):	.52M

Trade Size
Avg Trade Size (Sh.):	54
Avg Trade Size (Sh.) (30 D):	39
Avg Trade Size (Sh.) (90 D):	45

Institutional Trades
Total Institutional Trades:	2,651
Avg Institutional Trade:	$2.8M
Avg Institutional Trade (30 D):	$5M
Avg Institutional Trade (90 D):	$5.13M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.91M
Avg Closing Trade (30 D):	$7.17M
Avg Closing Trade (90 D):	$8.37M
Avg Closing Volume:	94.89K

News

May 15, 2026 @ 11:00 AM Kymera Therapeutics Announces Presentations on KT-... Source: Na

May 6, 2026 @ 11:00 AM Kymera Therapeutics to Participate in Upcoming May... Source: Not Specified

Apr 23, 2026 @ 11:00 AM Kymera Therapeutics to Report First Quarter 2026 F... Source: Na

Feb 25, 2026 @ 8:28 PM Protagonist Stock Up 120%, but One Fund Just Revea... Source: Jonathan Ponciano

Feb 25, 2026 @ 8:19 PM Disc Medicine Stock Is Swinging, but This Fund's N... Source: Jonathan Ponciano

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-3.69	$-.98	$-3.69
Diluted EPS	$-3.69	$-.98	$-3.69
Revenue	$39.21M	$2.87M	$39.21M
Gross Profit	$M	$M	$M
Net Income / Loss	$-311.35M	$-86.98M	$-311.35M
Operating Income / Loss	$-349.4M	$-97.9M	$-349.4M
Cost of Revenue	$39.21M	$2.87M	$39.21M
Net Cash Flow	$236.76M	$244.07M	$236.76M
PE Ratio